课题基金 / 基金详情

项目摘要

项目成果

Noel Southall的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Relaxin-3 is a relaxin/insulin-like family peptide that is expressed predominantly in the nucleus incertus. The nucleus incertus is a stress-responsive brainstem nucleus that projects widely to forebrain regions involved in anxiety, depression, eating, addiction, central processing of pain, and cognition. The cognate receptor for relaxin-3 is RXFP3, and studies of RXFP3 function using relaxin-3 and relaxin-3-derived peptide agonists and antagonists indicate that RXFP3 is a potential target for the treatment of anxiety disorders, depression and pain, among others. Novel small molecule RXFP3 agonists and antagonists will be valuable tools to elucidate the functions of relaxin-3 and its actions at RXFP3 receptors. During the reporting period, the team established a research plan and received RXP3-expressing cell lines to begin adaptation of an assay to enable high-throughput screening.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of substances that change alternative pre-mRNA splicing of the serotonin 2C receptor
Inhibitors of Cell Surface uPA Generation
Malaria Phosphatase Inhibitors Identified as a Potential New Malaria Treatment
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: